Skip to content

CGEN

Compugen Ltd.

NASDAQ · Healthcare · Biotechnology · IL

$2.59
+1.37%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue74.0M72.8M27.9M33.5M7.5M
Cost of Revenue9.7M9.3M7.9M2.0M975.0K
Gross Profit64.3M63.5M19.9M31.5M6.5M
Operating Expenses
R&D Expense24.6M22.8M24.8M34.5M30.6M
SG&A Expense9.4M9.4M10.0M10.0M11.3M
General & Admin Expense8.8M8.9M9.4M9.7M10.3M
Selling & Marketing Expense572.0K539.0K576.0K244.0K932.0K
Other Expenses
Total Operating Expenses34.0M32.2M34.8M44.4M41.9M
Cost and Expenses43.7M41.4M42.8M46.5M42.9M
Operating Income (EBIT)30.3M31.3M(14.9M)(13.0M)(35.4M)
Non-Operating
Interest Income3.4M4.4M5.2M3.2M1.4M
Interest Expense34.0K31.0K27.0K
Net Interest Income3.4M4.4M5.2M3.2M1.4M
Other Non-Op Income/Expense4.9M4.1M5.2M3.2M1.7M
Non-Operating Income (excl Interest)(4.9M)(4.1M)(5.2M)(3.2M)(1.8M)
EBT (Pre-Tax Income)35.2M35.4M(9.7M)(9.8M)(33.6M)
Income Tax Expense52.0K54.0K4.5M9.0M58.0K
Bottom Line
Net Income35.2M35.3M(14.2M)(18.8M)(33.7M)
Earnings from Cont. Ops35.2M35.3M(14.2M)(18.8M)(33.7M)
Earnings from Discont. Ops
Bottom Line Net Income35.2M35.3M(14.2M)(18.8M)(33.7M)
Per Share
Basic EPS$0.38$0.38($0.16)($0.21)($0.39)
Diluted EPS$0.38$0.38($0.16)($0.21)($0.39)
Revenue Per Share$0.78$0.78$0.31$0.38$0.09
Shares
Basic Shares Outstanding94.6M93.4M89.5M87.6M86.6M
Diluted Shares Outstanding94.6M93.8M89.5M87.6M86.6M
Profitability Metrics
EBITDA35.2M35.9M(9.2M)(9.3M)(33.1M)
D&A475.0K486.0K476.0K482.0K
EBIT35.2M35.4M(9.7M)(9.8M)(33.6M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026